Category Archives: Clinical Cardiology

As the number of COVID-19 casesand panicspreads throughout the globe, a picture is emerging as to what the direct cardiovascular effects of this particular coronavirus (SARS-CoV-2) might be and what the indirect impact will be on cardiologists and the patients in their care. Continue reading →

More time spent in ideal cardiovascular health, starting as early as childhood, is associated not only with less subclinical atherosclerosis, but also with significant improvements in cardiometabolic health and a lower risk of all-cause mortality, according to the results of two new studies published this week in JAMA Cardiology. In the first study, which was led by Vanessa Xanthakis, PhD (Boston University School of Medicine, MA), and Laura Corlin, PhD (Tufts University School of Medicine, Boston), longer durations of ideal or intermediate CV health in midlife were associated with lower risks of developing hypertension, diabetes, chronic kidney disease, CVD, and all-cause mortality when compared with men and women in poor CV health. You dont have to be perfect, but the closer you are to a better overall lifestyle, the better off you are, Xanthakis told TCTMD. Continue reading →

Cleveland Clinic and University Hospitals (UH) have partnered to provide drive-through COVID-19 testing for patients with a doctors order from UH or Cleveland Clinic. Continue reading →

Systemic sclerosis (SSc) myocarditis was found to occur more frequently in individuals with heart failure and a higher dyspnea class; SSc-myocarditis was also found to be associated with higher degrees of myocardial fibrosis, according to study results published in Rheumatology. According to the researchers, a comprehensive description and distinctive representation of SSc myocarditis is currently lacking, but it is needed to accurately identify the disease in its early stages to initiate therapy Continue reading →

A new study highlighted the relationship between ascending aortic dilatation and long-term endurance exercise in aging masters-level athletes. Continue reading →

Europe has a history of strong biomedical heart research and impactful clinical studies, which have resulted in improving cardiovascular health. Despite a period of decline in cardiovascular-related mortality thanks to the introduction of new treatments and prevention measures, cardiovascular disease (CVD) is levelling off and remains the leading cause of death worldwide and a major burden to society. Worryingly, there is a wrong perception that prevention is sufficient to tackle the burden of CVD Continue reading →

VANCOUVER, March 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc.("Neovasc" or the "Company") (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and minimally invasive devices for the treatment of refractory angina, announced today the Neovasc Reducer (the "Reducer") was featured in the peer reviewed publicationEuroIntervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and highlighted inPCR Online. Continue reading →

New Delhi: Turning a corner in interventional cardiology, advanced tools have opened new frontiers in heart care. Continue reading →

The acute aortic dissection detection risk score (ADD-RS), used alone or in combination with dimerized plasmin fragment D (D-dimer) was found to rule acute aortic syndrome (AAS) with high sensitivity, according to a systematic review and meta-analysis published inEuropean Heart Journal: Acute Cardiovascular Care. The investigators searched Cochrane Controlled Register of Trials, Embase, and MEDLINE, up to December 2018 for studies in which the accuracy of ADD-RS was examined. Two authors independently assessed selected studies for eligibility, and examined data on: patient demographics, sample size, study characteristics number of cases and controls, study setting methodological quality, ADD-RS cut-off value, D-dimer cutoff value (if appropriate), types of reference tests, and sensitivity and specificity Continue reading →

CAESAREA, Israel, March 02, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced that it has entered into a research collaboration agreement with Clalit Research Institute (CRI), a subsidiary of Clalit Health Services (CHS), Israels largest state-mandated health service organization. Continue reading →